Shelley G. Broader

October 14, 2026

Barclays Starts Coverage of Inspire Medical with Underweight. Barclays has begun coverage of Inspire Medical Systems and assigned an Underweight rating. The firm set a price target of $65 for the stock. This rating follows the recent analyst activity on the company. The stock is currently near its long‑term support level.

October 10, 2026

Vita Coco sees influencer marketing boost and analyst position changes. Co‑founder said influencer marketing is delivering better results than traditional advertising for Vita Coco. At the same time, Baird trimmed its holding in the company while Wells Fargo kept an overweight stance but cut its price target to $65. The news comes as China’s tariffs on U.S. agricultural products remain frozen, a factor that could influence demand for coconut water.

October 4, 2026

Dutch Bros shares near 52-week low amid mixed analyst views. Dutch Bros stock has fallen 21% in September, bringing it close to its 52-week low. While the company is exploring new walk-up locations, analysts like Baird and DA Davidson have recently lowered their price targets, though they still see potential upside. The stock currently trades well below the average analyst target of $72.92.